跳至主要内容
临床试验/NCT05178303
NCT05178303已完成4 期

Composition for Treating Cirrhosis and Liver Cancer

Nguyen Thi Trieu, MD2 个研究点 分布在 2 个国家目标入组 134 人开始时间: 2015年11月30日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
134
试验地点
2
主要终点
The test uses sound waves to measure the stiffness of liver tissue on patient cirrhosis (Arm 1)

研究概览

简要总结

The composition treats cirrhosis and hepatocellular carcinoma (Hcc) at an early stage. The product is extracted from herbs, including Adenosma glutinosum extract, Eclipta prostrata extract, Phyllanthus urinaria extract, Impatiens balsamina extract, Ascorbic acid, pyridoxine 5-phosphate, L-Arginine hydrochloride, Pregnenolone acetate. These components have participated in repairing and regenerating new liver parenchyma, preventing fibrosis cell generation, preventing liver cancer cell growth at an early stage. The composition supplements precursors which help the body strengthen antibodies and reduce the risk of inflammation, restore physiological and biochemical functions of liver cells after chronic inflammation.

详细描述

The composition is fractionally extracted from herbs. Flavonoids, isoflavonoids, and pregnenolone combined with ascorbic acid, pyridoxine 5-phosphate, L-arginine act as the key compounds in the regeneration of fibrosis liver cells, remove scar tissue, stimulate and release growth hormones, prevent progression to Hcc and prevent Hcc recurrence.

The pharmaceutical ingredients involved in the composition are calculated to increase their effectiveness in preventing and curing cirrhosis and Hcc.

Currently, many preparations have been and are being studied to fight against cirrhosis and liver cancer globally. The effectiveness of this preparation is a new finding which has been proven over 5 years of follow-up.

Pregnenolone is a cortisol precursor. Cortisol plays an important role in several systems in the body, including the immune system(in the cycle of the immune system to produce B lymphocytes). This ingredient is used as a supplement to stabilize the endothelium, regulate the amount of cortisol within normal limits, and help the body produce B lymphocytes with a good response.

Kaempferol is a flavonoid that participates in cell protection against toxic proteins which were produced during prolonged inflammation; blocking the action and removing denatured proteins that change the parenchyma of liver cells. The selected flavonoids repaired the fibrotic structure of liver parenchyma after chronic inflammation. Ascorbic acid, pyridoxine 5-phosphate, and L-arginine help to facilitate biological functions in cell adhesion, synergize with flavonoids in cell membrane protection, structural repair, and liver cell regeneration.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • All patients with underlying medical conditions who have been taking medications for these conditions.
  • Patients with AIDS, HIV, HBV, HCV, and patients with co-infections.
  • The cancer patients are stable.
  • Patients with congenital or acquired immunodeficiency.

排除标准

  • Unstable cancer patients.
  • Decompensated cirrhosis.

研究组 & 干预措施

Cirrhosis

Experimental

Experimental benefits in resistance to cirrhosis were observed in all patients who had previously received certain components of the treatment for cirrhosis SB-1121(1) for various therapeutic purposes.

干预措施: SB-1121(1) (Drug)

Cirrhosis/Hcc "stable"

Experimental

Experimental benefits in resistance to cirrhosis/Hcc were observed in all patients who had previously received certain components of the treatment for cirrhosis SB-1121(2) for various therapeutic purposes.

干预措施: SB-1121(2) (Drug)

结局指标

主要结局

The test uses sound waves to measure the stiffness of liver tissue on patient cirrhosis (Arm 1)

时间窗: 36 months

HBV, HCV,... injure healthy liver cells, causing cell death and inflammation. Healthy liver tissue is replaced with scar tissue and the liver is damaged.

次要结局

  • The test uses sound waves to measure the stiffness of liver tissue on patient cirrhosis/Hcc (Arm 2)(36 months)

研究者

发起方
Nguyen Thi Trieu, MD
申办方类型
Indiv
责任方
Sponsor Investigator
主要研究者

Nguyen Thi Trieu, MD

Scientific Manager

Trieu, Nguyen Thi, M.D.

研究点 (2)

Loading locations...

相似试验

Composition for Treating Cirrhosis and Liver Cancer... | 临床试验